FAQ

1. What is China Pharmaceuticals Inc.’s business?
China Pharmaceuticals, Inc. has its headquarters based in the industrial city of Xi’an, Shaanxi Province, China. The Company identifies, discovers, develops, manufactures, and distributes both prescription and over-the counter pharmaceutical products, including both conventional and traditional Chinese medicines, for the treatment of some of the most common ailments and diseases. China Pharmaceuticals Inc. currently manufactures 132 pharmaceutical products in 11 dosage forms including capsules, oral solutions, tablets, granules, syrups, medicinal teas, tincture and solutions for injection. The company currently markets and distributes 111 prescription drugs representing 78% of sales distributed via 56 sales offices (including 2 company-owned distribution and logistics centers) to a network of hospitals and clinics nation-wide. The Company operates 2 modern hi-tech manufacturing facilities, with 486 employees, based in Hanzhong and the Xi’an Jinghe Industrial Zone, both in Shaanxi Province.

2. What industries does China Pharmaceuticals, Inc. serve?
We currently sell our pharmaceutical products to numerous distributors who distribute our products pursuant to distribution agreements to licensed healthcare providers such as hospitals, clinics, and pharmacies in China. We currently have 35 active distribution agreements.

3. Does China Pharmaceuticals, Inc. have any subsidiaries? What exactly is the organizational structure?
Click here to see the China Pharmaceuticals Inc.'s SEC filings.

4. What is China Pharmaceuticals, Inc.’s ticker symbol, exchange, and CUSIP?
Our ticker symbol is CFMI and our common stock currently trades on the OTC:BB. Our CUSIP is 01989L106.

5. Where is China Pharmaceuticals, Inc. domiciled?
China Pharmaceuticals, Inc. is domiciled in the state of Nevada.

6. When was China Pharmaceuticals, Inc. founded?
Our wholly-owned operating subsidiary, Xi’an Qinba Pharmaceutical Co., Ltd. was founded in 1969 as a Limited Liability Company in the PRC.

7. How many China Pharmaceuticals, Inc.’s shares are outstanding?
As of March 31, 2011, there were 12,539,662 shares of our common stock outstanding.

8. When is the next earnings release?
China Pharmaceuticals, Inc.’s reported quarterly earnings releases are tentatively scheduled to be released 45 days following a quarter-end and 90 days following our fiscal year-end. All earnings releases will be posted on our website.

9. What is China Pharmaceuticals, Inc.’s fiscal year and corresponding quarter-end dates?
China Pharmaceuticals, Inc. operates on a calendar year, which runs from January 1 - December 31. Quarter-ends are: March 31, June 30, September 30, and December 31.

10. How can I get on an e-mail list to receive all press releases?
To receive all press releases and other financial reports via e-mail and to automatically receive email alerts for the information categories that interest you, please go to Investor Relations/Email Alerts and submit your email address.

11. Who is China Pharmaceuticals, Inc.’s Independent Certified Public Accountants?
China Pharmaceuticals, Inc.’s independent accounting firm is Acquavella, Chiarelli, Shuster, Berkower & Co., LLP Certified Public Accountants (1 Penn Plaza, 36th Floor, New York, NY 10119).

12. Who is China Pharmaceuticals, Inc.'s outside legal counsel?
China Pharmaceuticals, Inc.’s outside counsel is Sichenzia Ross Friedman Ference LLP, (61 Broadway, 32nd Floor, New York, NY 10006).

13. Who is the China Pharmaceuticals, Inc.’s Stock Transfer Agent?
China Pharmaceuticals, Inc.’s Transfer Agent is TranShare Corporation (5105 DTC Parkway, Suite 325, Greenwood Village, CO 80111).